Barclays’s Natural Health Trends NHTC Stock Holding History

Barclays’s Portfolio NHTC Stock Details NHTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-5,000	Closed	-$165K	–	6520
2016 Q1	$165K	Hold	5,000	–	–	﹤0.01%	3980
2015 Q4	$165K	Buy	+5,000	New	+$220K	﹤0.01%	4062

Other funds holding NHTC

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Barclays's NHTC Position: Q2 2025 in Review

Barclays sold out of Natural Health Trends (NHTC) in Q2 2025, closing a stake of 18 shares — an estimated $91 sold.

Barclays first reported a position in NHTC in Q2 2015 and held it in 21 quarters. The position peaked at $178K in Q2 2019. 21 funds tracked by Wall St. Rank hold NHTC as of Q2 2025.

Barclays reported no remaining Natural Health Trends position as of Q2 2025 after selling out during the quarter.
Barclays sold 18 Natural Health Trends shares in Q2 2025, an estimated $91.
Barclays first reported a position in Natural Health Trends in Q2 2015 and held it in 21 quarters.
Barclays's Natural Health Trends position peaked at $178K in Q2 2019.
21 funds tracked by Wall St. Rank held Natural Health Trends as of Q2 2025.

Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.